Don Campbell is the Vice President of Extramural Funding at the Gladstone Institutes, where he coordinates all external funding, structuring incoming commercial and donor funds. He also serves as administrative point-of-contact for the Gladstone Core Facilities. Mr. Campbell joined Gladstone in 2004 as a Senior Grants and Contracts Manager. Prior to coming to Gladstone, he worked at Stanford University and the Pacific Graduate School of Psychology in Palo Alto, California. He has 16 years’ experience in various research-administration roles and currently serves as the Interim President for the Northern California Chapter of the International Society of Research Administrators. Mr. Campbell received a bachelor’s degree in business administration, with a concentration in finance, from the University of Arizona in Tucson. He earned a Certified Research Administrator (CRA) designation in 2005.
Ann Carollo is Vice President for Philanthropy and Public Relations at the Gladstone Institutes. Ms. Carollo and her team tell the Gladstone story, illuminate the essential role of philanthropy, and encourage charitable contributions. The department responsibilities include communications, media relations, and fundraising. Ms. Carollo has 34 years of experience. Prior to joining Gladstone, she held senior positions at Sanford-Burnham Medical Research Institute (La Jolla, Calif., and Orlando, Fla.), the University of California, San Francisco, and Evanston Northwestern Healthcare (Evanston, Ill.). She spent her first decade fundraising with performing arts organizations, including the Sejong Cultural Center (Seoul, South Korea), American Symphony Orchestra League (Washington, DC), and The Music Center of Los Angeles. Ms. Carollo earned her bachelor’s degree from Scripps College in Claremont, Calif.
Stephen Freedman, PhD
Dr. Stephen B. Freedman is Director of the Gladstone Center for Translational Research (GCTR) and Vice President for Corporate Liaison and Ventures at the Gladstone Institutes. Through Dr. Freedman's leadership, GCTR has facilitated a number of significant strategic relationships and alliances—across all of Gladstone's research areas—with biotech and pharmaceutical companies, venture capital firms and foundations. GCTR is always looking for new opportunities to advance Gladstone's research through both traditional and non-traditional collaboration models. Dr. Freedman has more than 25 years of experience in the pharmaceutical industry, including senior positions at Merck & Co. and Elan Pharmaceuticals. Dr. Freedman earned a bachelor's degree in physiology and biochemistry and a PhD in pharmacology from the University of Southampton. He received the G. Kerkut Prize for Physiology in 1978 and completed postdoctoral studies with Professor Richard Miller at the University of Chicago.
Joan V. McIntyre, JD
Joan McIntyre is the Vice President for Intellectual Property and Legal Affairs at the Gladstone Institutes. Ms. McIntyre is responsible for all aspects of Gladstone’s intellectual property, including technology licensing and research-related agreements. She also serves as in-house counsel for general legal affairs. Ms. McIntyre joined Gladstone in 1997 and has more than 25 years of experience in intellectual property law—having worked in private practice, the medical-device industry and technology transfer for academia. She is admitted to practice before the U.S. Patent and Trademark Office, State of Minnesota, the Federal District Court of Minnesota, the Eighth Circuit Court of Appeals, the Court of Appeals for the Federal Circuit and as Registered In-House Counsel in the State of California. Ms. McIntyre is a registered U. S. Patent Attorney who earned a bachelor’s degree in medical microbiology at the University of Minnesota and a JD from the William Mitchell College of Law in St. Paul, Minn.
Vincent E. Moseley is the Vice President for Finance at the Gladstone Institutes. He is also the President and Treasurer of GRE, LLC—a Gladstone-controlled real-estate investment trust (REIT) and the Secretary of the Gladstone Foundation. Mr. Moseley is a Certified Public Accountant who has more than 20 years of management experience, with specialties in accounting, finance, operations, and mergers and acquisitions. Before joining Gladstone, Mr. Moseley worked in the audit and assurance departments of Coopers & Lybrand and BDO Seidman, and as a financial executive at pharmaceutical and information technology firms. Mr. Moseley received a bachelor’s degree in business administration from the University of Nevada, Las Vegas.
Michael L. Penn, Jr., MD, PhD
Dr. Michael L. Penn, Jr, MD, PhD is Vice President, Scientific Communications and Outreach at the Gladstone Institutes and Chief Executive Officer of the Gladstone Foundation, a 501(c)(3) organization that supports the Institutes. Additionally, Dr. Penn is responsible for integrating diversity and inclusion strategies into all of Gladstone’s core scientific and administrative activities. Prior to joining Gladstone in 2012 he worked for more than 8 years at Genentech Inc., where he helped advance innovations in drug development in marketing and business development roles of increasing responsibility. In 2001, Dr. Penn co-founded Building Diversity in Science, a nonprofit organization dedicated to empowering students to pursue careers in science. He also previously served as a Commissioner for San Francisco’s Health Commission, the policy-making board of the Department of Public Health. Dr. Penn earned a bachelor’s degree in biology from Morehouse College and an MD and PhD in biomedical sciences from the University of California, San Francisco.
John Whiting is the Vice President, Chief Financial and Administrative Officer at the Gladstone Institutes. He is also the Treasurer of the Gladstone Foundation. Mr. Whiting provides overall direction and leadership to Gladstone’s finance and administrative functions, which include Finance and Accounting; Extramural Funding and Grants & Contracts; Human Resources; Information Technology; Operations and Facilities Management; and Purchasing. His responsibilities include developing business strategy and leading Gladstone’s planning processes, which include the long- range strategic plan, budget and forecast. In addition, he provides oversight of Gladstone’s investment portfolio. Before joining Gladstone in 2010, Mr. Whiting was at Genentech Inc. for more than 20 years, most recently as Deputy Chief Financial Officer. Mr. Whiting earned both a bachelor’s degree in biology and an MBA at the University of Oregon. He is a CPA (inactive) licensed in California.